Sargramostim
In the US, Sargramostim (sargramostim systemic) is a member of the drug class colony stimulating factors and is used to treat Aplastic Anemia, Bone Marrow Transplantation, Bone Marrow Transplantation - Failure or Engraftment Delay, Bone Marrow Transplantation - Myeloid Reconstruction and Neutropenia Associated with Chemotherapy.
US matches:
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
L03AA09
CAS registry number (Chemical Abstracts Service)
0123774-72-1
Chemical Formula
C639-H1002-N168-O196-S8
Molecular Weight
14431
Therapeutic Categories
Immunomodulator
Colony stimulating factor, granulocyte-macrophage, GM-CSF
Chemical Name
23-L-Leucinecolony-stimulating factor 2 (human clone pHG25 protein moiety)
Foreign Names
- Sargramostimum (Latin)
- Sargramostim (German)
- Sargramostim (French)
- Sargramostim (Spanish)
Generic Names
- Sargramostim (OS: BAN, USAN, DCF)
- BI 61012 (IS)
- BL 400 (IS)
- rGM-CSF (IS)
- rHu GM-CSF (IS)
- Sargramostim (PH: USP 34)
Brand Names
International Drug Name Search
Glossary
| Term | Definition |
|---|---|
| BAN | British Approved Name |
| DCF | Dénomination Commune Française |
| IS | Inofficial Synonym |
| OS | Official Synonym |
| PH | Pharmacopoeia Name |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| USAN | United States Adopted Name |
Click for further information on drug naming conventions and International Nonproprietary Names.
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.
